Background Drugs to treat rare conditions orphan and ultraorphan drugs and drugs used to treat patients in their last months of life are contentious in funding decisions In 2014 the Scottish Medicines Consortium SMC introduced changes to its evaluations for medicines to treat such cond ID: 634521
Download Presentation The PPT/PDF document "Scotland’s End-of-Life, Orphan, and Ul..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
pptx